The disintegrin and metalloproteinase ADAM12 contributes to TGF-beta signaling through interaction with the type II receptor - Wikidata - awgldk - TriplyDB

The disintegrin and metalloproteinase ADAM12 contributes to TGF-beta signaling through interaction with the type II receptor

The disintegrin and metalloproteinase ADAM12 contributes to TGF-beta signaling through interaction with the type II receptor

http://www.wikidata.org/entity/Q36118798

about

Transforming growth factor beta engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab Identification of PCTA, a TGIF antagonist that promotes PML function in TGF-beta signalling Unravelling osteoarthritis-related synovial fibrosis: a step closer to solving joint stiffness Regulation of TGF-β Signal Transduction Maternal bisphenol a exposure impacts the fetal heart transcriptome Proteomic identification of ADAM12 as a regulator for TGF-β1-induced differentiation of human mesenchymal stem cells to smooth muscle cells Preferred SH3 domain partners of ADAM metalloproteases include shared and ADAM-specific SH3 interactions.IQGAP1 suppresses TβRII-mediated myofibroblastic activation and metastatic growth in liver Ablation of Indian hedgehog in the murine uterus results in decreased cell cycle progression, aberrant epidermal growth factor signaling, and increased estrogen signaling ADAM-12 as a diagnostic marker for the proliferation, migration and invasion in patients with small cell lung cancer.RACK1, a new ADAM12 interacting protein. Contribution to liver fibrogenesis.ADAM12 and ADAM17 gene expression in laser-capture microdissected and non-microdissected breast tumors.The role of SnoN in transforming growth factor beta1-induced expression of metalloprotease-disintegrin ADAM12.Simple Shared Motifs (SSM) in conserved region of promoters: a new approach to identify co-regulation patterns.Functional analysis of a breast cancer-associated mutation in the intracellular domain of the metalloprotease ADAM12 Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies.In silico QTL mapping of basal liver iron levels in inbred mouse strains The Roles of ADAMs Family Proteinases in Skin Diseases Endocytic regulation of TGF-beta signaling.Alternative mRNA splicing generates two distinct ADAM12 prodomain variants.The metalloprotease ADAM12 regulates the effector function of human Th17 cells.ADAM12 produced by tumor cells rather than stromal cells accelerates breast tumor progression.The Disintegrin and Metalloprotease ADAM12 Is Associated with TGF-β-Induced Epithelial to Mesenchymal Transition.Regulation of TGF-β receptor activity Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients Identification of ILK as a new partner of the ADAM12 disintegrin and metalloprotease in cell adhesion and survival PICK1 promotes caveolin-dependent degradation of TGF-β type I receptor.Breast cancer-associated mutations in metalloprotease disintegrin ADAM12 interfere with the intracellular trafficking and processing of the protein.ADAM12: a potential target for the treatment of chronic wounds Metalloproteinase-disintegrin ADAM12 is associated with a breast tumor-initiating cell phenotype.In silico investigation of ADAM12 effect on TGF-beta receptors trafficking.Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Inflammation and Fibrosis of Skeletal Muscles Down syndrome screening: imagining the screening test of the future.Post-translational regulation of TGF-β receptor and Smad signaling.Metalloproteinases in hypertension and cardiac disease: differential expression and mutual regulation.Ryk cooperates with Frizzled 7 to promote Wnt11-mediated endocytosis and is essential for Xenopus laevis convergent extension movements.Epithelial-to-Mesenchymal Plasticity Harnesses Endocytic Circuitries.Epigenetics and systemic sclerosis.Upregulation of ADAM12 contributes to accelerated cell proliferation and cell adhesion-mediated drug resistance (CAM-DR) in Non-Hodgkin's Lymphoma.SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor.

P2860

Q24313194-5FC353BC-69C6-4004-AF0E-C2BB9658041E Q24317578-5F05DFD6-3302-49C5-8828-6BF8CC15D829 Q26801739-62ED141B-63F7-4967-A9E4-450ADF995CD7 Q26996826-5262DB6E-8053-4C85-87E3-11EEF6B86F09 Q28540117-322AC666-2541-42F0-9C5D-D0146FA0F329 Q28727037-B8F52BD9-1B0F-4B12-BE4D-21F4B920DCF5 Q30009199-DD9DD61C-AB47-4F30-ACB5-149FAAF087DE Q30422218-A481FE2F-E027-40B4-B2A1-BEBCFC3ACB58 Q30432806-F34A796E-B849-4BA7-8DF7-1E2334066423 Q31148772-B69941F2-257D-41AC-A9E7-A413468A77DE Q33351256-959ED402-38F2-4D6B-8EC3-71494DE16279 Q33794994-856A22F3-6D93-4424-9457-75DDE6F66E9D Q33991229-22AE445B-F20A-4F7D-A21C-3A46BF125D4B Q34017089-3761CF15-7DD7-4CC0-86CA-C80B620B35F0 Q34291116-5AEBC706-F615-4DDE-83A4-A3816ADB7EBD Q34475490-1FCD164A-CEA9-4B66-ACD6-18BDDCFCB8BB Q34661915-F462F4EF-1173-4624-8C5D-05F1290C0ACC Q34669802-02D2B806-2CDA-45EA-B607-F93775B1CCCC Q34892916-CA1721D1-5D8B-4F62-A87C-2E446487C7DF Q35014541-D4E8B540-CD33-4E24-A815-E53EFD21C1D4 Q35074334-F3373F04-07ED-48C7-B58D-BD042E5B2BED Q35560725-A6181BD0-1ED1-4836-AF50-3ACEA21CDF88 Q35788620-3C9D276E-C50F-4648-BA4E-77D3DBB2D561 Q35905598-34FB8B73-E01F-4E61-BB46-AA3FFBC68919 Q36040200-86963DCB-81D9-4BF7-90D0-57DDD90530EC Q36202719-B775DA45-2F89-426B-BBD2-5B052DB55A10 Q36294546-DB30D189-BFA4-4332-A62B-A2B447AD115B Q37085961-28DB4EFC-BC0E-457F-B0C1-FA0DF63D8497 Q37173718-CA7C5FE3-1CE3-4B74-91F7-66AB3B2906F3 Q37352137-8105E0CC-17B5-494F-823B-1B328B77B4B5 Q37384212-CD1DDF21-F466-429B-8193-87960D24ABF2 Q37589790-D3C94609-B6BD-4EB4-8917-3D38572DFCA9 Q37750847-1FD6AD85-DA78-48D7-B048-F20932E50D26 Q38012228-B4FC1CF7-7F41-41A6-8FCB-EC5C8FB5B4D5 Q38224470-8F4DF09A-1EDD-4EE2-9A77-C80085F3011D Q38360630-D7BB4B94-B290-4901-AD2F-BCD17B6275D7 Q38376446-4E19E68D-9E6B-47E6-8628-4631BF38CE91 Q38544948-B3C847D5-FE41-4D98-9349-9A900EB30969 Q38843959-798412A2-C6FC-4DEA-BD2D-E432662FA5C7 Q38868773-ACB3DA55-D2A5-41B9-8ED5-643DBBF9F2C4

P2860

The disintegrin and metalloproteinase ADAM12 contributes to TGF-beta signaling through interaction with the type II receptor

http://www.wikidata.org/entity/Q36118798

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

The disintegrin and metallopro ...... tion with the type II receptor

@ast

The disintegrin and metallopro ...... tion with the type II receptor

@en

type

label

The disintegrin and metallopro ...... tion with the type II receptor

@ast

The disintegrin and metallopro ...... tion with the type II receptor

@en

prefLabel

The disintegrin and metallopro ...... tion with the type II receptor

@ast

The disintegrin and metallopro ...... tion with the type II receptor

@en

P1433

Q36118798-772421D3-B87E-4F45-B605-8BA5E89ADCB1

P1476

Q36118798-46B615BE-7A75-4EE4-BBBD-76828D24BD7A

P2093

Q36118798-07440D7E-AADE-4C9E-8E97-E52F6B298014

Q36118798-315E1339-8351-4450-82BF-33F5F1BB21EC

Q36118798-39284E3D-BAD4-4C66-A69B-DB10ABDDAE60

Q36118798-670E267A-7A1A-483B-B922-CFA37A2C0E9B

Q36118798-75D8FA1B-25A0-4D04-955C-387FD3EED4F2

Q36118798-812614C5-75A8-4A20-91AD-17DD89629004

Q36118798-8224AA17-4787-4747-876F-2281295A7788

Q36118798-8BDA6012-108D-425F-863B-831D9B984A4C

Q36118798-97D36FE0-2113-4914-BB7D-EBFBCF316201

Q36118798-CD41A1AE-8614-4D5B-9A4A-A55448B3785A

P2860

Q36118798-0746C522-070E-47E4-B245-F98AB5EA6C21

Q36118798-0FB49D25-8A74-44FD-8B54-26B618111BC1

Q36118798-2A185752-EAA3-4EBA-A51A-81817F533D51

Q36118798-2F077C5F-2AE5-4E38-B2CD-01958590DCEE

Q36118798-33C23243-8950-4CA3-810E-07ADE3EFC7EE

Q36118798-37D3551F-AE53-43CB-99AA-D1C6F0F98DCA

Q36118798-462B42CF-CD59-4AE0-A4C5-627B22B29073

Q36118798-56EE405C-C5F2-45CF-BCE3-675C881274E8

Q36118798-5B0BE83C-6F89-4B1E-AB7A-EF11091C7F52

Q36118798-6147C9DB-3401-4853-989F-CEBEAED7E998

P304

Q36118798-B8EADA52-6526-4FDF-B491-BC196D8D5DAC

P31

Q36118798-7A73B227-FE21-49FA-B7C9-F2A0FDC7EA89

P356

Q36118798-C304D8A5-7A2E-4CC2-8C19-319D13F7E118

P407

Q36118798-7F3DCE13-4312-45BB-B73A-1BFC714701AC

P433

Q36118798-41AE8761-BA1A-4BD9-AA65-264AADC6AC3F

P478

Q36118798-7FA14023-AA46-491F-A6CA-8EFE4EAE47A2

P50

Q36118798-67A44C1F-9965-4518-B8E9-CD1E86269CC0

P577

Q36118798-C9A77610-8D69-4A13-8B00-8F16A46915F5

P5875

Q36118798-E506D5D8-CA1B-4DF0-9290-2432E4517820

P698

Q36118798-C263B60B-8429-49B1-AB36-5FA4D0DE808F

P932

Q36118798-93D321A7-6E36-4487-A875-6DB90A6F2CDD

P356

P1433

Journal of Cell Biology

P1476

The disintegrin and metallopro ...... tion with the type II receptor

@en

P2093

Annie L'helgoualc'h

http://www.w3.org/2001/XMLSchema#string

Azeddine Atfi

http://www.w3.org/2001/XMLSchema#string

Bruno Clément

http://www.w3.org/2001/XMLSchema#string

Céline Prunier

http://www.w3.org/2001/XMLSchema#string

Dominique Bonnier

http://www.w3.org/2001/XMLSchema#string

Emmanuelle Dumont

http://www.w3.org/2001/XMLSchema#string

Frédéric Colland

http://www.w3.org/2001/XMLSchema#string

Nathalie Ferrand

http://www.w3.org/2001/XMLSchema#string

Nathalie Théret

http://www.w3.org/2001/XMLSchema#string

Ulla M Wewer

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of ADAM12, a marker of skeletal muscle regeneration, to the muscle-specific actin-binding protein, alpha -actinin-2, is required for myoblast fusion

Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation

Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation

Functional proteomics mapping of a human signaling pathway

A metalloprotease-disintegrin participating in myoblast fusion

A novel, secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo

The novel E3 ubiquitin ligase Tiul1 associates with TGIF to target Smad2 for degradation

ADAM 12, a disintegrin metalloprotease, interacts with insulin-like growth factor-binding protein-3

ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3

Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor

P304

201-208

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1083/JCB.200612046

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

178

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-07-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6218337

http://www.w3.org/2001/XMLSchema#string

P698

17620406

http://www.w3.org/2001/XMLSchema#string

P932

2064440

http://www.w3.org/2001/XMLSchema#string